CY1117507T1 - COMPOSITION FOR SUSPENSION - Google Patents
COMPOSITION FOR SUSPENSIONInfo
- Publication number
- CY1117507T1 CY1117507T1 CY20151100923T CY151100923T CY1117507T1 CY 1117507 T1 CY1117507 T1 CY 1117507T1 CY 20151100923 T CY20151100923 T CY 20151100923T CY 151100923 T CY151100923 T CY 151100923T CY 1117507 T1 CY1117507 T1 CY 1117507T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compositions
- suspension
- composition
- proteasome inhibitors
- cyclodextrin
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Οι συνθέσεις που περιλαμβάνουν έναν ή περισσότερους αδιάλυτους πρακτικά αναστολείς πρωτεασώματος και κυκλοδεξτρίνη, ιδιαίτερα μια υποκατεστημένη κυκλοδεξτρίνη, ουσιαστικά αυξάνουν τη διαλυτότητα αυτών των αναστολέων πρωτεασώματος και διευκολύνουν τη χορήγηση τους. Αυτές οι συνθέσεις περιλαμβάνουν προαιρετικά ένα ρυθμιστικό. Οι μέθοδοι θεραπευτικής αντιμετώπισης χρησιμοποιώντας αυτές τις συνθέσεις κοινοποιούνται επίσης.Compositions comprising one or more practically insoluble proteasome inhibitors and cyclodextrin, particularly a substituted cyclodextrin, substantially increase the solubility of these proteasome inhibitors and facilitate their administration. These compositions optionally include a buffer. Methods of treatment using these compositions are also disclosed.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63436604A | 2004-12-07 | 2004-12-07 | |
US65593005A | 2005-02-23 | 2005-02-23 | |
EP10179422.0A EP2261236B1 (en) | 2004-12-07 | 2005-12-07 | Composition for proteasome inhibition |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117507T1 true CY1117507T1 (en) | 2017-04-26 |
Family
ID=58449087
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20131100432T CY1114025T1 (en) | 2004-12-07 | 2013-05-30 | COMPOSITION FOR SUSPENSION |
CY20151100923T CY1117507T1 (en) | 2004-12-07 | 2015-10-15 | COMPOSITION FOR SUSPENSION |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20131100432T CY1114025T1 (en) | 2004-12-07 | 2013-05-30 | COMPOSITION FOR SUSPENSION |
Country Status (1)
Country | Link |
---|---|
CY (2) | CY1114025T1 (en) |
-
2013
- 2013-05-30 CY CY20131100432T patent/CY1114025T1/en unknown
-
2015
- 2015-10-15 CY CY20151100923T patent/CY1117507T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CY1114025T1 (en) | 2016-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111489T1 (en) | COMPOUNDS FOR SUSPENSION | |
NO2020031I1 (en) | cobimetinib, including pharmaceutically acceptable salts and solvates, in particular cobimetinib hemifumarate | |
CY1116693T1 (en) | A combination of azelastin and cycloneside | |
CY1113192T1 (en) | UNIONS AND METHODS FOR THE SUSPENSION OF SUSPENSION PROGRESS THROUGH AURORA SUSPENSION | |
CY1113386T1 (en) | PROJECTOR SUSPENSIONS | |
CY1113963T1 (en) | PHARMACEUTICAL COMPOSITIONS WHICH INCLUDE ACTIVIA-COMPETITORS AND USE THESE IN PREVENTION OR MULTIPLE | |
CY1116373T1 (en) | PHARMACEUTICAL PARTICLES CONTAINING METHYLNALTREXON | |
EA200701065A1 (en) | INJECTABLE COMPOSITIONS CONTAINING NANODISPERS Olanzapine | |
NO20081554L (en) | Isoindollide compounds and compositions comprising the same, and their use | |
CY1106679T1 (en) | AZADICYCLIC HETEROCYCLIC COMPOUNDS AS CANNABINOID RECEPTOR MODIFIERS | |
MXPA05013977A (en) | Methods and compositions for treating amyloid-related diseases. | |
RS54614B1 (en) | Dimethoxy docetaxel acetone solvate et method for the preparation thereof | |
EA200501928A1 (en) | Pyrrolodihydroisoquinols as inhibitors of PDE10 | |
CY1109916T1 (en) | Benzimidazolo-thiophene compounds as PLK inhibitors | |
CY1111983T1 (en) | PHARMACEUTICAL COMPOSITION AND METHOD OF USE OF ANTIFICIAL AGENT IN COMBINATION | |
CY1109465T1 (en) | NEW PHARMACEUTICAL MEDICINES FORMONTAFINILIS | |
CY1112591T1 (en) | FROM THE ORAL PHARMACEUTICAL FORMS OF CLANDRIVIN | |
EA200801414A1 (en) | CALCYLYTIC COMPOUNDS | |
NO20063293L (en) | Pharmaceutical compounds | |
EA200601596A1 (en) | IMPROVED 6-MERCAPTOPURIN COMPOSITION | |
CY1117507T1 (en) | COMPOSITION FOR SUSPENSION | |
CY1114113T1 (en) | COMBINATION OF A VASCULAR IF VASCULAR INHIBITOR AND A BETA-INHIBITOR | |
CY1114807T1 (en) | 2,4-Pyrimidinodiamine Compounds for Therapeutic Treatment or Prevention of Autoimmune Diseases | |
CY1114511T1 (en) | CARBONYLAMINE PYRROLOPYRAZOLES, POSSIBLE CHINASE INHIBITORS |